Quick Answer
Wave Life Sciences Ltd. reported Operating Income Loss of -$215.38 million for the year ending 2025.
- Wave Life Sciences Ltd. showed a decrease of -95.1% in Operating Income Loss from 2024 to 2025.
- This data is from Wave Life Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: -$1.35 million | Q1 2015: -$3.47 million | Q2 2015: -$3.63 million | Q3 2015: -$4.99 million | Q4 2015: -$7.21 million | Q1 2016: -$7.95 million | Q2 2016: -$11.64 million | Q3 2016: -$17.23 million | Q4 2016: -$18.50 million | Q1 2017: -$20.21 million | Q2 2017: -$24.67 million | Q3 2017: -$26.35 million | Q4 2017: -$31.16 million | Q1 2018: -$35.78 million | Q2 2018: -$36.57 million | Q3 2018: -$38.23 million | Q4 2018: -$48.94 million | Q1 2019: -$47.99 million | Q2 2019: -$45.62 million | Q3 2019: -$54.18 million | Q4 2019: -$60.53 million | Q1 2020: -$49.99 million | Q2 2020: -$38.66 million | Q3 2020: -$34.42 million | Q1 2021: -$43.47 million | Q2 2021: -$39.83 million | Q3 2021: -$7.61 million | Q1 2022: -$38.09 million | Q2 2022: -$42.16 million | Q3 2022: -$38.90 million | Q1 2023: -$30.29 million | Q2 2023: -$23.47 million | Q3 2023: $4.44 million | Q1 2024: -$34.46 million | Q2 2024: -$35.00 million | Q3 2024: -$63.92 million | Q1 2025: -$49.80 million | Q2 2025: -$52.76 million | Q3 2025: -$56.35 million.
- Over the full 13 years of available data (2013 to 2025), Wave Life Sciences Ltd.'s Operating Income Loss has declined by 5,926.4%.
- Historical annual values: Fiscal year 2025: -$215.38 million | Fiscal year 2024: -$110.40 million | Fiscal year 2023: -$68.00 million | Fiscal year 2022: -$162.72 million | Fiscal year 2021: -$127.02 million | Fiscal year 2020: -$153.38 million | Fiscal year 2019: -$208.32 million | Fiscal year 2018: -$159.52 million | Fiscal year 2017: -$102.39 million | Fiscal year 2016: -$55.72 million | Fiscal year 2015: -$19.30 million | Fiscal year 2014: -$5.39 million | Fiscal year 2013: -$3.57 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: